UEFA made €3.1 billion from Champions League rights, up from €569 million in the 2003/04 season
profits
The New York-based drug company on Tuesday said it now expects to end the year with revenue in the range of $99.5 billion to $102 billion
Soaring prices have more than compensated Russia for the loss in sales volume due to sanctions
Pfizer reported its fourth-quarter and full-year results on Tuesday
It was the biggest single-day drop in market capitalization in U.S. corporate history
Despite the challenges posed by the coronavirus pandemic, Apple’s share price climbed by 34 percent in 2021
According to a report by the People’s Vaccine Alliance, In contrast, AstraZeneca and Johnson & Johnson sell their vaccines at a cost price.
Apple leads the way
Cancer appears to be the most profitable disease for big pharma
"I believe Q2 was a clear and powerful demonstration of the capabilities of the new @Pfizer", tweeted CEO Albert Bourla